SION Stock Analysis: Buy, Sell, or Hold?
SION - Sionna Therapeutics, Inc. Common Stock
$43.99
2.35 (5.64%)
▲
5d:
+2.85%
30d:
+20.59%
90d:
+6.51%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When SION Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SION shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SION shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SION is currently trading at $43.99, which is considered extended relative to its 30-day fair value range of $35.55 to $42.56.
Technical Outlook: Technically, SION is in a uptrend. The price is approaching resistance at $45.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.6% recently.
Market Sentiment: SION has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (79th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $51.60 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SION is in a uptrend. The price is approaching resistance at $45.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.6% recently.
Market Sentiment: SION has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (79th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $51.60 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$35.55 -
$42.56
Company Quality Score
55/100
(HOLD)
Options IV Signal
79th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
52.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Options expensive (IV 79th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.6%)
- BULLISH: Trading below Wall St target ($51.60)
Trading Range Analysis
30-Day Trading Range
$35.55 -
$42.56
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$12.03
(27.4%)
Support & Resistance Levels
Support Level
$36.63
Resistance Level
$45.00
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.70
Wall Street Target
$51.60
(+17.3%)
Share & Embed Analysis
Last updated: July 02, 2026 10:34 PM ET
Data refreshes hourly during market hours. Next update: 11:34 PM
Data refreshes hourly during market hours. Next update: 11:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SION showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter A Thompson
SELL
2948 shares
2026-04-18
Orbimed Advisors Llc
SELL
2948 shares
2026-04-18
Orbimed Advisors Llc
SELL
52397 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
